Molecular-biological markers of hereditary COPD, respiratory oxalosis (RO) Source: Eur Respir J 2002; 20: Suppl. 38, 261s Year: 2002
Chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MS) Source: Eur Respir J 2006; 28: Suppl. 50, 249s Year: 2006
Evaluation of the differences of small airways impairment between chronic obstructive disease (COPD) and bronchiolitis obliterans syndrome (BOS) by using impulse oscillometory Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010
Respiratory infections in patients with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms Year: 2009
Pulmonary rehabilitation (PR) exercise tolerance improvement: Differences between interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions Year: 2013
Asthma-COPD overlap syndrome (ACOS) versus ²pure² COPD: A distinct phenotype? Source: International Congress 2016 – Best abstracts in asthma and COPD Year: 2016
Can chronic obstructive lung disease (COPD) criteria be used to manage bronchiectasis (BR) and obliterative bronchiolitis (OB) in children surviving severe lung infection? Source: Eur Respir J 2001; 18: Suppl. 33, 172s Year: 2001
Metabolic syndrome (MS) in COPD patients entering pulmonary rehabilitation (PR) Source: Annual Congress 2008 - Assessing profiles of rehabilitation candidates Year: 2008
Hemodynamic features of pulmonary hypertension (PH) in ARDS Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016
Isolated mosaic pattern due to bronchiolitis in non-transplant patients: Etiology in 60 cases Source: International Congress 2015 – Interstitial lung diseases I Year: 2015
Differential therapy of acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) patients with predominance of emphysema (PE) and predominance of bronchitis (PB) Source: Eur Respir J 2006; 28: Suppl. 50, 395s Year: 2006
Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD) Source: International Congress 2015 – Connective tissue disorders Year: 2015
Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus Source: Eur Respir J 2008; 31: 213-217 Year: 2008
Pulmonary rehabilitation (PR) outcomes in chronic obstructive pulmonary disease (COPD) compared with interstitial lung disease (ILD) Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD Year: 2011
Genetics variants in familial interstitial pneumonia and progressive fibrosing interstitial lung disease (PF-ILD) Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis Year: 2021
Early pulmonary phenotype in Hermansky-Pudlak syndrome: Analysis of the chILD-EU registry Source: International Congress 2016 – Paediatric bronchology I Year: 2016
Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Clinical experience with nintedanib for the treatment of IPF in 80 cases Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016
Pulmonary function in patients recovering from severe acute respiratory syndrome (SARS) Source: Eur Respir J 2004; 24: Suppl. 48, 239s Year: 2004
The functional capacity of children with post-infectious obliterative bronchiolitis Source: International Congress 2016 – What's new in paediatric respiratory physiology? Year: 2016